サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514225

バイオフォトニクスの世界市場

Biophotonics
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 214 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
バイオフォトニクスの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオフォトニクスの世界市場は2030年までに2,275億米ドルに達する見込み

2023年に1,108億米ドルと推定されるバイオフォトニクスの世界市場は、2030年には2,275億米ドルに達し、分析期間2023-2030年のCAGRは10.8%で成長すると予測されます。本レポートで分析したセグメントの1つであるシースルーイメージングアプリケーションは、CAGR 0.1%を記録し、分析期間終了時には341億米ドルに達すると予測されます。インサイドイメージングアプリケーションセグメントの成長率は、分析期間でCAGR 8.8％と推定されます。

米国市場は301億米ドルと推定、中国はCAGR10.3%で成長予測

米国のバイオフォトニクス市場は、2023年に301億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに353億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.2%と9.1%と予測されています。欧州では、ドイツがCAGR約9.3%で成長すると予測されています。

世界のバイオフォトニクス市場動向と促進要因まとめ

バイオフォトニクスは生物学とフォトニクスの交差点であり、科学者が光を用いて分子から細胞、組織まで生物学的物質を探索し操作する方法に革命をもたらしています。この分野は、吸収、散乱、発光による光の相互作用を利用することで、ミクロなレベルで生命を研究できるという基本原理に基づいています。バイオフォトニクスの歴史は光学顕微鏡の発明にまで遡ることができます。超解像蛍光顕微鏡のような現代の進歩は、細胞イメージングの限界を大きく広げ、研究者は10ナノメートルまでの構造を見ることができるようになりました。バイオフォトニクスの進化は、イメージングと分析技術の次元、解像度、感度、特異性の向上によって顕著であり、リアルタイムで現場での分析を提供するポイントオブケア機器のニーズの高まりによって拍車がかかっています。

臨床や環境において、バイオフォトニクスは非常に有用です。内視鏡検査、フローサイトメトリー、蛍光in situハイブリダイゼーション（FISH）などの技術は、がん診断において極めて重要であり、眼科では、光干渉断層計（OCT）やレーシックなどの技術革新が患者の転帰を変えています。製薬分野でも、創薬プロセスにおいて極めて重要なマルチパラメーター蛍光検出を利用したハイスループットスクリーニング法の恩恵を受けています。医療にとどまらず、バイオフォトニクスは環境モニタリングや農業にも及んでおり、そこでは機械学習と統合された光学センサーが生産性と持続可能性を大幅に向上させています。この技術の多様な応用は、様々な空間的・時間的スケールで動作する能力、低侵襲性、他の技術との互換性によって推進され、科学研究や実用的な応用において万能なツールとなっています。

バイオフォトニクスの成長には、いくつかの重要な要因があります。イメージングとセンシング技術の進歩は、解像度の向上と組織への深い浸透を実現し、複雑な生物学的調査に不可欠です。人工知能の統合はデータ解析を向上させ、バイオフォトニクスをより効率的で広く応用できるものにします。OCTのような技術が安全性と利便性から好まれるようになり、非侵襲的医療処置に対する消費者の需要も増加しています。さらに、バイオフォトニックデバイスの規制承認と標準化により、その安全性と有効性が確保され、臨床現場での採用が促進されています。学界、研究室、産業界のコラボレーションは技術革新に不可欠であり、バイオフォトニック技術の開発と商業化を加速させています。個別化医療が重視されるようになると、診断や治療の選択肢をカスタマイズする上で重要な役割を果たすため、バイオフォトニクスの需要がさらに高まる。従来の医療分野だけでなく、環境や食品の安全性にも応用が広がるにつれ、バイオフォトニクスの可能性は拡大し続け、バイオフォトニック技術の認知度や採用率を高める教育訓練プログラムの増加によって、その重要性が強調されています。

調査対象企業の例（全83件）

  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • IDEX Corporation
  • IPG Photonics Corporation
  • Koninklijke Philips NV
  • Procter & Gamble Company, The
  • Qiagen, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-6870

Global Biophotonics Market to Reach US$227.5 Billion by 2030

The global market for Biophotonics estimated at US$110.8 Billion in the year 2023, is expected to reach US$227.5 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2023-2030. See-through Imaging Application, one of the segments analyzed in the report, is expected to record a 0.1% CAGR and reach US$34.1 Billion by the end of the analysis period. Growth in the Inside Imaging Application segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.1 Billion While China is Forecast to Grow at 10.3% CAGR

The Biophotonics market in the U.S. is estimated at US$30.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.3 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 9.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Biophotonics Market - Key Trends and Drivers Summarized

Biophotonics, an intersection of biology and photonics, is revolutionizing how scientists explore and manipulate biological materials—from molecules to cells and tissues—using light. This field builds on the fundamental principle that light interactions, through absorption, scattering, or emission, can be harnessed to study life at microscopic levels. The history of biophotonics can be traced back to the invention of the optical microscope, which first allowed the detailed visual exploration of biological tissues. Modern advancements, such as super-resolution fluorescence microscopy, have significantly pushed the boundaries of cellular imaging, allowing researchers to view structures down to 10 nanometers. The evolution of biophotonics has been marked by enhancements in dimensionality, resolution, sensitivity, and specificity of imaging and analysis techniques, spurred by the growing need for point-of-care devices that offer real-time, in-field analysis.

In clinical and environmental settings, biophotonics is proving invaluable. Techniques like endoscopy, flow cytometry, and fluorescence in situ hybridization (FISH) are pivotal in cancer diagnostics, while in ophthalmology, innovations like Optical Coherence Tomography (OCT) and LASIK are transforming patient outcomes. The pharmaceutical field also benefits from high-throughput screening methods that utilize multiparameter fluorescence detection, crucial in the drug discovery process. Beyond medicine, biophotonics extends to environmental monitoring and agriculture, where optical sensors integrated with machine learning significantly enhance productivity and sustainability. This technology’s diverse applications are driven by its ability to operate across various spatial and temporal scales, its minimally invasive nature, and its compatibility with other technologies, making it a versatile tool in scientific research and practical applications.

The growth of biophotonics is fueled by several key factors. Advances in imaging and sensing technologies, which offer enhanced resolution and deeper tissue penetration, are crucial for complex biological investigations. The integration of artificial intelligence improves data analysis, making biophotonics more efficient and widely applicable. Consumer demand for non-invasive medical procedures is also increasing, as technologies like OCT become preferred for their safety and convenience. Additionally, regulatory approvals and standardization across biophotonic devices ensure their safety and efficacy, encouraging their adoption in clinical settings. Collaborations between academia, research labs, and industry are vital for innovation, speeding up the development and commercialization of biophotonic technologies. The growing emphasis on personalized medicine further drives the demand for biophotonics, as it plays a critical role in enabling customized diagnostic and treatment options. As applications expand beyond traditional medical fields into environmental and food safety, the potential for biophotonics continues to grow, underscored by increased educational and training programs that raise awareness and adoption of biophotonic technologies.

Select Competitors (Total 83 Featured) -

  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • IDEX Corporation
  • IPG Photonics Corporation
  • Koninklijke Philips NV
  • Procter & Gamble Company, The
  • Qiagen, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biophotonics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Non-Invasive Diagnostic Techniques Throws the Spotlight on Biophotonics
    • Advances in Optical Technologies Propel Growth in the Biophotonics Market
    • Rising Adoption of Biophotonics in Medical Imaging Drives Market Expansion
    • Expanding Applications in Oncology Expands Addressable Market Opportunity
    • Innovations in Light-Based Therapies Generate Demand for Advanced Biophotonics Solutions
    • Increasing Focus on Personalized Medicine Accelerates Demand for Biophotonics Technologies
    • Shifts towards Minimally Invasive Procedures Impacts the Market
    • Increasing Focus on Biomedical Research Spur Market Growth
    • Adoption of Biophotonics in Telemedicine and Remote Diagnostics Expands Usage of Technologies
    • Growing Awareness about Biophotonics Propel Market Demand
    • Rising Investment in Healthcare and Biotechnology Innovations Strengthens the Business Case for Biophotonics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biophotonics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biophotonics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for See-through Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for See-through Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Inside Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Inside Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Spectro Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Spectro Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surface Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Surface Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Light Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Light Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Tests & Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Tests & Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Medical Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Medical Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Medical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Medical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Non-Medical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Non-Medical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Non-Medical Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Non-Medical Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Biophotonics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Biophotonics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biophotonics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Biophotonics by Application - See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Biophotonics by Application - Percentage Breakdown of Value Sales for See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy and Biosensors for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of World Recent Past, Current & Future Analysis for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of World Historic Review for Biophotonics by End-Use - Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of World 16-Year Perspective for Biophotonics by End-Use - Percentage Breakdown of Value Sales for Tests & Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application and Non-Medical Applications for the Years 2014, 2024 & 2030

IV. COMPETITION